{"id":"W4200447938","doi":"10.1093/ofid/ofab466.1072","title":"877. North American Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes","year":2021,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Rilpivirine; Medicine; Population; Internal medicine; Regimen; Human immunodeficiency virus (HIV); Viral load; Virology; Antiretroviral therapy; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004656474,0.0003116718,0.0005912363,0.00007656933,0.0004024337,0.0001853083,0.00008691855,0.00002875305,0.0001074027],"category_scores_gemma":[0.000136978,0.0002196951,0.00005882186,0.000360964,0.0002916934,0.0002460729,0.0002945318,0.0001199672,0.00001402269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007401149,"about_ca_system_score_gemma":0.0001746256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002695833,"about_ca_topic_score_gemma":0.001896781,"domain_scores_codex":[0.9985518,0.00005776569,0.0002503489,0.0005460497,0.0002080945,0.0003859615],"domain_scores_gemma":[0.9989585,0.0001565616,0.0001324353,0.0003059854,0.00007293984,0.0003736276],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004760726,0.0009756985,0.9457659,0.00002417654,0.0002556297,0.0006679901,0.0003522029,0.000003858985,0.00001561235,0.00003911991,0.0001035955,0.05132012],"study_design_scores_gemma":[0.007402969,0.0007049456,0.986381,0.00005919935,0.000324232,0.0002813678,0.000957288,0.00002353652,0.0001716226,0.00001368684,0.003370942,0.0003092191],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944403,0.0003992473,0.0001083173,0.001644329,0.00004905364,0.0006887395,0.00004202034,0.00009678422,0.002531243],"genre_scores_gemma":[0.9957978,0.0004117232,0.0002612681,0.0007539743,0.00001921561,0.00009974864,0.0001447637,0.00003142423,0.002480125],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0510109,"threshold_uncertainty_score":0.8958907,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01139738430684836,"score_gpt":0.3088464482955847,"score_spread":0.2974490639887364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}